Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users. Fertil Steril 2008 Sep;90(3):872-5

Date

12/25/2007

Pubmed ID

18155704

DOI

10.1016/j.fertnstert.2007.01.046

Scopus ID

2-s2.0-51449094458 (requires institutional sign-in at Scopus site)   19 Citations

Abstract

The effect of mifepristone on the expression of secretory leukocyte protease inhibitor (SLPI) in the endometrium of women using depot medroxyprogesterone acetate (DMPA) was investigated in this randomized, placebo-controlled trial. The study showed that the administration of DMPA led to a substantial inhibition of endometrial SLPI protein and mRNA, and that the addition of mifepristone to DMPA-exposed endometrium partially restored the expression of glandular SLPI.

Author List

Li A, Felix JC, Yang W, Jain JK

Author

Juan Felix MD Vice Chair, Director, Professor in the Pathology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Contraceptive Agents, Female
Contraceptives, Oral, Synthetic
Drug Interactions
Endometrium
Female
Gene Expression
Humans
Medroxyprogesterone Acetate
Mifepristone
Placebo Effect
Secretory Leukocyte Peptidase Inhibitor